- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03812471
Optimization of Fetal Biometry With 3D Ultrasound and Image Recognition (EPICEA)
April 13, 2023 updated by: Philips Electronics Nederland B.V. acting through Philips CTO organization
In the proposed clinical investigation, the investigational device (BabySize3D) will provide automated plane extraction and automated biometry measurements from 3D US volumes.
The results obtained from the investigational software
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
265
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nancy, France, 54511
- CHRU de Nancy Brabois
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- evolutive pregnancy with one fetus with a Gestational Age between 16 and 30 weeks
- aged between 18 and 65 years.
- social welfare benefit recipient
- willing and able to provide informed consent
Exclusion Criteria:
- under 18 years old
- multiple pregnancy
- over 18 years old and mentioned in French law articles L.1126-6 et L-1126-8,
- fetal malformation or suspected fetal malformation
- technical conditions that do not allow for standard fetal biometry (abdominal wall, fetal position, BMI > 25 kg/m2)
- fetal biometry non indicated in the standard pregnancy follow-up
- unwilling or unable to provide informed consent (e. g. physical, mental disability or linguistic factor that compromises patient information)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Main study: 3D volumes acquisitions
3D volume acquisitions
|
2 abdominal volumes 2 thigh volumes 2 head volumes
|
|
Experimental: Ancillary study: 2D and 3D acquisitions
2D standard measurements and 3D volumes acquisitions
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bi-parietal diameter in mm.
Time Frame: Day 1
|
The bi-parietal diameter in mm will be obtained with three methods: (1) fully automated 3D volume processing and caliper placement, (2) manual 3D volume processing and caliper placement, (3) manual selection of the 2D view plane and manual caliper placement on the screen of the ultrasound system (corresponding to standard of care measurements).
The values obtained with the three methods and the differences between these values will be reported.
|
Day 1
|
|
Head circumference in mm
Time Frame: Day 1
|
The Head circumference in mm will be obtained with three methods: (1) fully automated 3D volume processing and caliper placement, (2) manual 3D volume processing and caliper placement, (3) manual selection of the 2D view plane and manual caliper placement on the screen of the ultrasound system (corresponding to standard of care measurements).
The values obtained with the three methods and the differences between these values will be reported.
|
Day 1
|
|
Abdominal circumference in mm
Time Frame: Day 1
|
The Abdominal circumference in mm will be obtained with three methods: (1) fully automated 3D volume processing and caliper placement, (2) manual 3D volume processing and caliper placement, (3) manual selection of the 2D view plane and manual caliper placement on the screen of the ultrasound system (corresponding to standard of care measurements).
The values obtained with the three methods and the differences between these values will be reported.
|
Day 1
|
|
Femur length in mm
Time Frame: Day 1
|
The Femur length in mm will be obtained with three methods: (1) fully automated 3D volume processing and caliper placement, (2) manual 3D volume processing and caliper placement, (3) manual selection of the 2D view plane and manual caliper placement on the screen of the ultrasound system (corresponding to standard of care measurements).
The values obtained with the three methods and the differences between these values will be reported
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Failure rate of the automated measurements
Time Frame: Day 1
|
Failure rate of the automated measurements
|
Day 1
|
|
Exam and post-processing duration
Time Frame: Day 1
|
Exam and post-processing duration
|
Day 1
|
|
Difference of scores of the 2D standard cephalic plane and cephalic plane extracted from the 3D volume, based on six criteria listed in (Salomon et al. Ultrasound Obstet Gynecol 2006; 27: 34-40)
Time Frame: Day 1
|
The cephalic plane extracted from the 3D volume and the 2D standard cephalic plane will be scored according to the six criteria described in (Salomon et al.
Ultrasound Obstet Gynecol 2006; 27: 34-40).
The scores and their difference will be reported.
|
Day 1
|
|
Difference of scores of the 2D standard abdominal plane and abdominal plane extracted from the 3D volume, based on six criteria listed in (Salomon et al. Ultrasound Obstet Gynecol 2006; 27: 34-40)
Time Frame: Day 1
|
The abdominal plane extracted from the 3D volume and the 2D standard abdominal plane will be scored according to the six criteria described in (Salomon et al.
Ultrasound Obstet Gynecol 2006; 27: 34-40).
The scores and their difference will be reported.
|
Day 1
|
|
Difference of scores of the 2D standard femoral plane and femoral plane extracted from the 3D volume, based on four criteria listed in (Salomon et al. Ultrasound Obstet Gynecol 2006; 27: 34-40)
Time Frame: Day 1
|
The femoral plane extracted from the 3D volume and the 2D standard femoral plane will be scored according to the four criteria described in (Salomon et al.
Ultrasound Obstet Gynecol 2006; 27: 34-40).
The scores and their difference will be reported.
|
Day 1
|
|
Difference of scores of (i) the 2D standard cephalic plane and of (ii) the frames of a sequence of 2D images including the fetus head (cine-loop), based on six criteria listed in (Salomon et al. Ultrasound Obstet Gynecol 2006; 27: 34-40)
Time Frame: Day 1
|
The 2D standard cephalic plane and the frames of a sequence of 2D images including the fetus head will be scored according to the six criteria described in (Salomon et al.
Ultrasound Obstet Gynecol 2006; 27: 34-40).
The scores and the score difference (standard view score - frame score) will be reported.
|
Day 1
|
|
Difference of scores of (i) the 2D standard abdominal plane and of (ii) the frames of a sequence of 2D images including the fetus abdomen (cine-loop), based on six criteria listed in (Salomon et al. Ultrasound Obstet Gynecol 2006; 27: 34-40)
Time Frame: Day 1
|
The 2D standard abdominal plane and the frames of a sequence of 2D images including the fetus abdomen will be scored according to the six criteria described in (Salomon et al.
Ultrasound Obstet Gynecol 2006; 27: 34-40).
The scores and the score difference (standard view score - frame score) will be reported.
|
Day 1
|
|
Difference of scores of (i) the 2D standard femoral plane and of (ii) the frames of a sequence of 2D images including the fetus femur (cine-loop), based on four criteria listed in (Salomon et al. Ultrasound Obstet Gynecol 2006; 27: 34-40)
Time Frame: Day 1
|
The 2D standard femoral plane and the frames of a sequence of 2D images including the fetus femur will be scored according to the four criteria described in (Salomon et al.
Ultrasound Obstet Gynecol 2006; 27: 34-40).
The scores and the score difference (standard view score - frame score) will be reported.
|
Day 1
|
|
Title: Intraclass correlation coefficient of the bi-parietal diameter in mm (same operator)
Time Frame: Day 1
|
The intraclass correlation coefficient of the bi-parietal diameter in mm measured from two different 3D volumetric acquisitions of the same patient performed by the same operator will be calculated.
|
Day 1
|
|
Bland-Altman representation of the bi-parietal diameter in mm (same operator)
Time Frame: Day 1
|
A Bland-Altman representation of the the bi-parietal diameter in mm measured from two different 3D volumetric acquisitions of the same patient performed by the same operator will be built.
|
Day 1
|
|
Intraclass correlation coefficient of the bi-parietal diameter in mm (different operators)
Time Frame: Day 1
|
The intraclass correlation coefficient of the bi-parietal diameter in mm measured from the 3D volumetric acquisitions of the same patient performed by two different operators will be calculated.
|
Day 1
|
|
Bland-Altman representation of the bi-parietal diameter in mm (different operators)
Time Frame: Day 1
|
A Bland-Altman representation of the bi-parietal diameter in mm measured from the 3D volumetric acquisitions of the same patient performed by two different operators will be built.
|
Day 1
|
|
Intraclass correlation coefficient of the head circumference in mm (same operator)
Time Frame: Day 1
|
the intraclass correlation coefficient of the head circumference in mm measured from two different 3D volumetric acquisitions of the same patient performed by the same operator will be calculated.
|
Day 1
|
|
Bland-Altman representation of the head circumference in mm (same operator)
Time Frame: Day 1
|
A Bland-Altman representation of the head circumference in mm measured from two different 3D volumetric acquisitions of the same patient performed by the same operator will be built.
|
Day 1
|
|
Intraclass correlation coefficient of the head circumference in mm (different operators)
Time Frame: Day 1
|
The intraclass correlation coefficient of the head circumference in mm measured from the 3D volumetric acquisitions of the same patient performed by two different operators will be calculated.
|
Day 1
|
|
Bland-Altman representation of the head circumference in mm (different operators)
Time Frame: Day 1
|
A Bland-Altman representation of the head circumference in mm measured from the 3D volumetric acquisitions of the same patient performed by two different operators will be built.
|
Day 1
|
|
Intraclass correlation coefficient of the abdominal circumference in mm (same operator)
Time Frame: Day 1
|
The intraclass correlation coefficient of the abdominal circumference in mm measured from two different 3D volumetric acquisitions of the same patient performed by the same operator will be calculated.
|
Day 1
|
|
Bland-Altman representation of the abdominal circumference in mm (same operator)
Time Frame: Day 1
|
A Bland-Altman representation of the abdominal circumference in mm measured from two different 3D volumetric acquisitions of the same patient performed by the same operator will be built.
|
Day 1
|
|
Intraclass correlation coefficient of the abdominal circumference in mm (different operators)
Time Frame: Day 1
|
The intraclass correlation coefficient of the abdominal circumference in mm measured from the 3D volumetric acquisitions of the same patient performed by two different operators will be calculated.
|
Day 1
|
|
Bland-Altman representation of the abdominal circumference in mm (different operators)
Time Frame: Day 1
|
A Bland-Altman representation of the abdominal circumference in mm measured from the 3D volumetric acquisitions of the same patient performed by two different operators built.
|
Day 1
|
|
Intraclass correlation coefficient of the femoral length in mm (same operator)
Time Frame: Day 1
|
The intraclass correlation coefficient of the femoral length in mm measured from two different 3D volumetric acquisitions of the same patient performed by the same operator will be calculated.
|
Day 1
|
|
Bland-Altman representation of the femoral length in mm (same operator)
Time Frame: Day 1
|
A Bland-Altman representation of the femoral length in mm measured from two different 3D volumetric acquisitions of the same patient performed by the same operator will be built.
|
Day 1
|
|
Title: Intraclass correlation coefficient of the femoral length in mm (different operators)
Time Frame: Day 1
|
The intraclass correlation coefficient of the femoral length in mm measured from the 3D volumetric acquisitions of the same patient performed by two different operators will be calculated.
|
Day 1
|
|
Bland-Altman representation of the femoral length in mm (different operators)
Time Frame: Day 1
|
A Bland-Altman representation of the femoral length in mm measured from the 3D volumetric acquisitions of the same patient performed by two different operators will be built.
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Gaëlle Gaëlle AMBROISE-GRANDJEAN, CHRU de Nancy
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 23, 2018
Primary Completion (Actual)
March 11, 2021
Study Completion (Actual)
March 17, 2023
Study Registration Dates
First Submitted
September 6, 2018
First Submitted That Met QC Criteria
January 18, 2019
First Posted (Actual)
January 23, 2019
Study Record Updates
Last Update Posted (Actual)
April 14, 2023
Last Update Submitted That Met QC Criteria
April 13, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- ICBE-2-24301
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.